Lack of disease control remains a major barrier to transplant for older patients with AML

Bone Marrow Transplant. 2023 Sep;58(9):1054-1056. doi: 10.1038/s41409-023-02022-3. Epub 2023 Jun 23.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Leukemia, Myeloid, Acute* / therapy